Market Currents
Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it...
-
Monday, December 31, 2012, 1:44 PM ETPeregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it had entered into an At Market Issuance Sales Agreement with MLV & Co. to sell up to $75M in stock. The biotech firm also said it issued options to purchase 200K shares each to CEO Steven King and CFO Paul Lytle under the company's stock incentive plan.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
